Non-coding ncRNAs (ncRNAs) are transcriptional production which do not coding proteins, with a spectrum of diversified type, and function (Chen and Kim, 2024). Although the ncRNAs have many types including the long noncoding RNAs (lncRNAs), microRNAs (miRNAs), small nucleolar RNAs (snoRNAs), transfer RNA (tRNA), ribosomal RNA (rRNA), circular RNA (circRNA) etc., most of them are lncRNA and miRNA. In 1984, the first regulatory ncRNA, microRNA F (micF) was discovered from E. coli. MicF inhibits the translation of OmpF by binding to its ribosome-binding site, blocking ribosome entry (Mizuno et al., 1984;Corcoran et al., 2012).Over the past 40 years, numerous regulatory non-coding RNAs (ncRNAs), such as Let-7, enod40, H19, and NEAT1, have been identified as key regulators in animals or plants (Bartolomei et al., 1991;Crespi et al., 1994;Pasquinelli et al., 2000;Hutchinson et al., 2007). Studies have demonstrated the crucial roles of ncRNAs-particularly miRNAs and lncRNAs-in development, metabolism, and disease (Kallen et al., 2013;Tripathi et al., 2013;Chen and Kim, 2024). However, most of the ncRNA world is still unknown.To provide new insights and a deeper understanding of the functional and regulatory roles of ncRNAs, we curated six articles for the "The Non-Coding RNA World in Animals and Plants" topic. These papers include original research on ncRNAs in tobacco, common carp (Cyprinus carpio L.), and pulmonary hypertension, as well as reviews on ncRNAs in endocrine disorders, eye diseases, and intrahepatic cholestasis of pregnancy.Xie et al. analyzed 549 publicly available RNA-Seq datasets from tobacco and identified 30,212 lncRNAs (Xie et al., 2022). These lncRNAs exhibit distinct characteristics compared to coding genes, including fewer exons, higher A/U content, and greater tissue specificity. Functional analysis of the potential targets of these lncRNAs revealed their association with nicotine biosynthesis, their findings further validated through topping treatment. This study advances our understanding of the functional roles of lncRNAs in tobacco and provides new candidate genes for regulating nicotine production.Ledesma-Pacheco et al. presented our current understanding regarding the miRNAs' regulatory mechanism of the endocrine disorders and their potential influence as disease biomarkers during their development processes by overviewing recent and significant research outputs (Ledesma-Pacheco et al., 2023). This review illuminated the most recent information related to the potential functions of miRNAs in endocrine disorders, including diabetes mellitus, thyroid diseases, osteoporosis, etc., and their novel diagnostic and therapeutic purposes. It will enhance our knowledge of miRNAs' roles in endocrine disorders and facilitate the development of novel miRNA-based diagnostic and therapeutic tools for endocrine disorder.Benavides-Aguilar et al. integrated recent studies on miRNA in common eye diseases to illustrate the regulatory roles of miRNAs in the eye-related diseases such as cataracts, glaucoma, and macular degeneration (Benavides-Aguilar et al., 2023). This review provides valuable insights into the potential applications of miRNAs in the prognosis and treatment of these eye-related disorders.Das et al. integrated 468 raw RNA-Seq datasets from 28 tissues in common carp (Cyprinus carpio L.), a substitute vertebrate fish model for zebrafish, to identify the lncRNAs and circular RNAs using various bioinformatics tools (Das et al., 2023). They conducted the lncRNA-miRNA-mRNA interaction network analysis and introduced CCncRNAdb, a comprehensive web resource (http://backlin.cabgrid.res.in/ccncrnadb/) to facilitate further exploration of ncRNAs in common carp.Xiong et al. consolidates recent discoveries on miRNA, lncRNA, circRNA, etc. for the intrahepatic cholestasis of pregnancy (ICP) to discuss their potential as diagnostic markers, prognostic tools, and therapeutic targets, offering a foundation for improving early detection and personalized treatment of ICP (Xiong et al., 2023).Chen et al. conducted a comprehensive study on the peripheral blood samples of Pulmonary hypertension (PH) patients and healthy individuals through whole-genome miRNA sequencing and transcriptome analysis, exploring the potential role of miRNAs in PH (Chen et al., 2023). By screening the differentially expressed miRNAs, they identified four miRNAs (hsa-miR-1304-3p, hsa-miR-490-3p, hsa-miR-11400, and hsa-miR-31-5p) as potential clinical diagnostic biomarkers for PH. This finding provides a valuable foundation for further understanding the specific role of miRNAs in the mechanisms of PH, opening new avenues for early diagnosis and precision medicine in PH.In summary, these articles expand our current knowledge of ncRNAs and deepen our understanding of the non-coding RNA world.LW, BH, MJH, and QZZ all contributed to writing and revising the original draft.The author(s) declare that no grant support.
Editorial07 February 2025
Editorial: The non-coding RNA world in animals and plantsORIGINAL RESEARCH
19 January 2023
Investigating nicotine pathway-related long non-coding RNAs in tobacco
Xiaodong Xie, 6 more and Yalong Xu
8 Authors
- XX
Xiaodong Xie
China Tobacco Gene Research Center, China
- JJ
Jingjing Jin
China Tobacco Gene Research Center, China
- CW
Chen Wang
China Tobacco Gene Research Center, China
- PL
Peng Lu
China Tobacco Gene Research Center, China
- ZL
Zefeng Li
China Tobacco Gene Research Center, China
- JT
Jiemeng Tao
China Tobacco Gene Research Center, China
- PC
Peijian Cao
China Tobacco Gene Research Center, China
- YX
Yalong Xu
China Tobacco Gene Research Center, China
Long noncoding RNAs (lncRNAs) are transcripts longer than 200bp with low or no protein-coding ability, which play essential roles in various biological processes in plants. Tobacco is an ideal model plant for studying nicotine biosynthesis and metabolism, and there is little research on lncRNAs in this field. Therefore, how to take advantage of the mature tobacco system to profoundly investigate the lncRNAs involved in the nicotine pathway is intriguing. By exploiting 549 public RNA-Seq datasets of tobacco, 30,212 lncRNA candidates were identified, including 24,084 large intervening noncoding RNAs (lincRNAs), 5,778 natural antisense transcripts (NATs) and 350 intronic noncoding RNAs (incRNAs). Compared with protein-coding genes, lncRNAs have distinct properties in terms of exon number, sequence length, A/U content, and tissue-specific expression pattern. lincRNAs showed an asymmetric evolutionary pattern, with a higher proportion (68.71%) expressed from the Nicotiana sylvestris (S) subgenome. We predicted the potential cis/trans-regulatory effects on protein-coding genes. One hundred four lncRNAs were detected as precursors of 30 known microRNA (miRNA) family members, and 110 lncRNAs were expected to be the potential endogenous target mimics for 39 miRNAs. By combining the results of weighted gene co-expression network analysis with the differentially expressed gene analysis of topping RNA-seq data, we constructed a sub-network containing eight lncRNAs and 25 nicotine-related coding genes. We confirmed that the expression of seven lncRNAs could be affected by MeJA treatment and may be controlled by the transcription factor NtMYC2 using a quantitative PCR assay and gene editing. The results suggested that lncRNAs are involved in the nicotine pathway. Our findings further deepened the understanding of the features and functions of lncRNAs and provided new candidates for regulating nicotine biosynthesis in tobacco.


